Sandoval Elisabeth
Insider CIK 1632295 · XENT Director · ALDR Chief Commercial Officer · KYTH Chief Commerical Officer · MNLO Director · PRCT Director · STSA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics Corp | A Award deriv | 2026-06-09 | 2026-06-10 | 5,853 | — | $0 | 5,853 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | A Award | 2026-06-09 | 2026-06-10 | 3,315 | — | $0 | 15,876 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2025-12-12 | 2025-12-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | A Award deriv | 2025-06-10 | 2025-06-12 | 2,771 | — | $0 | 2,771 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | A Award | 2025-06-10 | 2025-06-12 | 1,538 | — | $0 | 12,561 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2024-12-12 | 2024-12-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | A Award deriv | 2024-06-04 | 2024-06-06 | 2,526 | — | $0 | 2,526 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | A Award | 2024-06-04 | 2024-06-06 | 1,376 | — | $0 | 11,023 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2024-01-01 | 2024-01-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2023-12-13 | 2023-12-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | A Award deriv | 2023-06-15 | 2023-06-16 | 4,865 | — | $0 | 4,865 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | A Award | 2023-06-15 | 2023-06-16 | 2,711 | — | $0 | 9,647 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 14,893 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 10,000 | — | $0 | 0 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2022-08-10 | 2022-08-12 | 20,500 | — | $0 | 20,500 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | A Award deriv | 2022-06-07 | 2022-06-09 | 4,205 | — | $0 | 4,205 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | A Award | 2022-06-07 | 2022-06-09 | 2,001 | $37.48 | $75.0K | 6,936 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| XENT Intersect ENT, Inc. | U Tender deriv | 2022-05-13 | 2022-05-16 | 15,896 | $28.25 | $449.1K | 0 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | A Award | 2021-10-21 | 2021-10-25 | 4,935 | $40.46 | $199.7K | 4,935 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2021-07-19 | 2021-07-20 | 20,500 | — | $0 | 20,500 | SEC↗ |
| XENT Intersect ENT, Inc. | A Award deriv | 2021-04-05 | 2021-04-07 | 15,896 | — | $0 | 15,896 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-08-03 | 2020-08-05 | 22,500 | — | $0 | 22,500 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2020-06-12 | 2020-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-19 | 2020-03-23 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 11,645 | — | $0 | 45,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-03-19 | 2019-03-21 | 33,355 | — | $0 | 33,355 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2018-02-16 | 2018-02-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2017-12-20 | 2017-12-21 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2017-01-27 | 2017-01-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2016-10-05 | 2016-10-07 | 225,000 | — | $0 | 225,000 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | D To issuer deriv | 2015-10-01 | 2015-10-02 | 45,588 | — | $0 | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | D To issuer deriv | 2015-10-01 | 2015-10-02 | 6,700 | — | $0 | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | D To issuer deriv | 2015-10-01 | 2015-10-02 | 45,344 | — | $0 | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | D To issuer deriv | 2015-10-01 | 2015-10-02 | 15,608 | — | $0 | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | D To issuer | 2015-10-01 | 2015-10-02 | 575 | — | $0 | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | M Exercise deriv | 2015-09-23 | 2015-09-24 | 11,892 | — | $0 | 4,857 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | M Exercise deriv | 2015-09-23 | 2015-09-24 | 13,400 | — | $0 | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | M Exercise deriv | 2015-09-23 | 2015-09-24 | 11,150 | — | $0 | 15,608 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | M Exercise deriv | 2015-09-23 | 2015-09-24 | 13,400 | — | $0 | 6,700 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | M Exercise deriv | 2015-09-23 | 2015-09-24 | 22,690 | — | $0 | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | S Sale | 2015-09-23 | 2015-09-24 | 11,892 | $74.90 | $890.7K | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | M Exercise | 2015-09-23 | 2015-09-24 | 11,150 | $44.02 | $490.8K | 11,150 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | S Sale | 2015-09-23 | 2015-09-24 | 11,150 | $74.90 | $835.1K | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | S Sale | 2015-09-23 | 2015-09-24 | 22,690 | $74.90 | $1.70M | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | M Exercise | 2015-09-23 | 2015-09-24 | 22,690 | $8.22 | $186.5K | 22,690 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | S Sale | 2015-09-23 | 2015-09-24 | 26,800 | $74.90 | $2.01M | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | M Exercise | 2015-09-23 | 2015-09-24 | 11,892 | $8.22 | $97.8K | 11,892 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | M Exercise | 2015-09-23 | 2015-09-24 | 26,800 | $27.50 | $737.0K | 26,800 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | M Exercise deriv | 2015-09-22 | 2015-09-24 | 10,590 | — | $0 | 16,749 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | M Exercise | 2015-09-22 | 2015-09-24 | 10,590 | $8.22 | $87.0K | 10,590 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | S Sale | 2015-09-22 | 2015-09-24 | 10,590 | $74.90 | $793.2K | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | S Sale | 2015-08-05 | 2015-08-06 | 2,728 | $74.75 | $203.9K | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | S Sale | 2015-04-30 | 2015-04-30 | 1,654 | $45.55 | $75.3K | 2,728 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | A Award | 2015-04-29 | 2015-04-30 | 4,382 | — | $0 | 4,382 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | A Award deriv | 2015-01-29 | 2015-02-02 | 45,344 | — | $0 | 45,344 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | A Award deriv | 2015-01-29 | 2015-02-03 | 45,344 | — | $0 | 45,344 | SEC↗ |